» Authors » Breogan Rodriguez Acevedo

Breogan Rodriguez Acevedo

Explore the profile of Breogan Rodriguez Acevedo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 3
Citations 20
Followers 0
Related Specialty
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Cobo-Calvo A, Carbonell-Mirabent P, Tur C, Otero-Romero S, Carvajal R, Arrambide G, et al.
Neurology . 2025 Feb; 104(4):e210305. PMID: 39903901
Background And Objectives: Emerging concepts in the early detection of multiple sclerosis (MS) progression reveal that disability accumulation can start early in the disease course. Aging in MS is increasingly...
2.
Comabella M, Pappolla A, Monreal E, Fissolo N, Sao-Aviles A, Arrambide G, et al.
Neurol Neuroimmunol Neuroinflamm . 2025 Jan; 12(2):e200370. PMID: 39879564
Background And Objectives: Invasive procedures may delay the diagnostic process in multiple sclerosis (MS). We investigated the added value of serum neurofilament light chain (sNfL), glial fibrillary acidic protein (sGFAP),...
3.
Bollo L, Arrambide G, Cobo-Calvo A, Alvarez J, Alberich M, Cabello S, et al.
Neurology . 2024 Mar; 102(7):e209156. PMID: 38447105
Background And Objectives: We aimed to assess the presence of retinal neurodegeneration independent of optic neuritis (ON) in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and to investigate the development of...
4.
Cobo-Calvo A, Tur C, Otero-Romero S, Carbonell-Mirabent P, Ruiz M, Pappolla A, et al.
Neurology . 2023 Jul; 101(13):e1280-e1292. PMID: 37468284
Background And Objectives: Early treatment is associated with better long-term outcomes in patients with a first demyelinating event and early multiple sclerosis (MS). However, magnetic resonance (MR) findings are not...
5.
Zabalza A, Arrambide G, Tagliani P, Cardenas-Robledo S, Otero-Romero S, Esperalba J, et al.
Neurol Neuroimmunol Neuroinflamm . 2022 Feb; 9(2). PMID: 35105687
Background And Objectives: Information about humoral and cellular responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and antibody persistence in convalescent (COVID-19) patients with multiple sclerosis (PwMS) is scarce....